Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets

Suye Zhong1, Na Wang1, Chun Zhang1

  • 1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

Diabetic kidney disease (DKD) involves podocyte cell death. This review examines apoptosis, necrosis, and other death pathways in podocytes, offering insights for future DKD therapeutic strategies.

Area of Science:

  • Nephrology and Diabetes Complications
  • Cellular Biology and Pathophysiology

Background:

  • Cell death is crucial for tissue homeostasis but aberrant cell death contributes to disease.
  • Diabetic kidney disease (DKD) is a major diabetes complication characterized by high mortality.
  • Podocyte loss and detachment are central pathological features driving DKD progression.

Purpose of the Study:

  • To review the mechanisms of various cell death modalities in podocytes within the context of DKD.
  • To explore how different cell death pathways contribute to the pathogenesis and progression of DKD.
  • To highlight current research and future therapeutic strategies targeting podocyte cell death in DKD.

Main Methods:

  • Comprehensive literature review of basic and clinical research studies.
  • Analysis of mechanisms including apoptosis, necrosis, autophagy, pyroptosis, ferroptosis, cuproptosis, and podoptosis.
  • Focus on studies investigating the role of these cell death pathways in podocytes during DKD.

Main Results:

  • Multiple cell death pathways (apoptosis, necrosis, pyroptosis, ferroptosis, cuproptosis, podoptosis) are implicated in podocyte injury in DKD.
  • These diverse cell death mechanisms collectively contribute to podocyte loss and kidney damage.
  • Current research identifies specific pathways as potential therapeutic targets.

Conclusions:

  • Targeting specific podocyte cell death pathways presents a promising therapeutic avenue for DKD.
  • Further research is needed to fully elucidate the roles of each cell death mode and develop effective treatments.
  • Interventions aimed at modulating podocyte cell death could mitigate DKD progression and improve patient outcomes.